No Picture
Trading Ideas

AstraZeneca resumes trials of COVID vaccine halted by patient illness

AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after receiving the green light from safety watchdogs, the company said on Saturday. The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout. “On 6 September, the standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators,” AstraZeneca said. …read more […]

No Picture
Trading Ideas

Oil Traders Snap Up Tankers in Sign Second-Wave Glut Is Near

(Bloomberg) — Some of the world’s biggest oil traders are gearing up for a possible resurgence of a coronavirus-induced glut of crude and fuels, snapping up giant tankers for months-long charters so that they can be ready to store excess barrels if necessary.The chartering spree is likely to alarm Saudi Arabia, Russia and their allies as it indicates that the oil traders believe the crude market is moving into a surplus after OPEC+ managed to create a deficit earlier this summer with its output cuts.Trafigura Group, the world’s second-largest independent oil trader, in recent days booked about a dozen supertankers …read more […]

No Picture
Trading Ideas

Warren Buffett Buys GOLD?

During their recent episode of the VALUE: After Hours Podcast, Taylor, Brewster, and Carlisle discussed Buffett Buys Barrick Gold Corp (NYSE:GOLD). Here’s an excerpt from the episode: Buffett Buys Barrick Gold Tobias: Yeah, let’s segue. I’m reading Chris Bloomstran’s because Chris follows Berkshire closer than anybody else. It’s interesting, Berkshire upped their buyback but sold a whole […] …read more […]

No Picture
Trading Ideas

Merkel Scrapping Nord Stream Would Unravel German Gas Strategy

(Bloomberg) — As Angela Merkel weighs up the arguments for scrapping a Russian pipeline project, a cornerstone of the German chancellor’s carefully crafted energy strategy is at stake.Merkel is coming under increasing pressure to ditch the Nord Stream 2 pipeline after the poisoning of Russian opposition politician Alexey Navalny. Members of her own party have questioned the project and Polish Prime Minister Mateusz Morawiecki said the decision should be a “no brainer.”But cancellation would mean unwinding years of government strategy to turn Germany into a lucrative gas hub as it boosts supplies of the fossil fuel during the green energy …read more […]

No Picture
Trading Ideas

FAA to begin key Boeing 737 MAX training review on Monday in London

A training review for the grounded Boeing 737 MAX will begin on Monday in London, the U.S. Federal Aviation Administration (FAA) said, in a key milestone for the plane’s eventual return to service. The FAA said the Joint Operations Evaluation Board for the Boeing 737 MAX will take place at London Gatwick Airport and meet for approximately nine days “to review Boeing’s proposed training for 737 MAX flight crews” and will include civil aviation authorities and airline flight crews from the United States, Canada, Brazil and the European Union. There are several other key steps to be …read more […]

No Picture
Trading Ideas

Amarin (AMRN): Vascepa’s International Opportunity Remains Intact, Says Analyst

The markets might be in turmoil, but spare a thought for the current woes at biotech Amarin (AMRN). Over the past 7 trading sessions, shares have retreated by 44% as investors charged to the exit doors following a botched date in court.Last week, an appeals court rejected Amarin’s appeal concerning a lost patent court case against generic drug makers Hikma Pharmaceuticals and Dr. Reddy’s, who are seeking to bring to market their own versions of Amarin’s high triglyceride treatment Vascepa.As Vascepa is Amarin’s only product, the ruling has obviously spooked investors, who are concerned the treatment’s vast commercial opportunity is …read more […]

No Picture
Trading Ideas

This Penny Gold Stock Could Rocket Higher

Gold stocks are performing really well across the board…
However, there is an outlier…
In fact, this gold producer is currently trading at the same levels that it was trading in the beginning of the year. Other gold stocks have doubled or even tripled since then.

What makes this story even more surprising is that CEO Rob McEwen was the founder of Goldcorp, one of the biggest gold mining companies on the planet. After its recent merger with Newmont Mining, it was valued in the billions.
McEwen Mining (NYSE: MUX) is currently worth around $500 million, and Rob McEwen is the largest shareholder, owning …read more […]

No Picture
Trading Ideas

TikTok Pushing Forward With Deal to Meet Looming Deadline

(Bloomberg) — TikTok is pressing forward with plans for a sale of its U.S. operations ahead of a mid-September deadline, according to a person familiar with the matter, even as signs emerge that the video-sharing app is facing pressure to shut down rather than make a deal.The app, owned by China’s ByteDance Ltd., is still considering bids from two possible buyers — Oracle Corp. and Microsoft Corp., which has teamed up with Walmart Inc. TikTok intends to bring a proposal to the White House for approval before a deadline imposed by U.S. President Donald Trump, said the person, who asked …read more […]

No Picture
Trading Ideas

Tesla Is a ‘Buy’ Ahead of the Upcoming Battery Day, Says Oppenheimer

Tesla (TSLA) stock has taken investors on quite the roller-coaster ride. It is now trading at $372.72 per share, down 25% this month, which in turn reflects a 13% rise from $330 per share just a few days prior. The tech rally’s poster boy was hit the hardest during the recent downturn, and its exclusion from the latest S&P 500 reshuffle has soured sentiment somewhat. However, Tesla has a big catalyst on the horizon, in the shape of the much-anticipated Battery Day, which will take place on September 22.Oppenheimer analyst Colin Rusch expects Musk and Co. to shine a light …read more […]

No Picture
Trading Ideas

UBS raises Peloton price target but remains neutral on the stock

UBS analysts led by Eric Sheridan raised their price target on shares of Peloton from $85 to $58, but kept their ‘neutral’ rating on the stock. The firm sees Peloton as a business “that is poised to con’t to capitalize on shifting consumer behavior toward more in-home and health safety workout regimes.” The Final Round panel discusses the call. …read more […]